The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study
Autor: | Pasi Ohtonen, Sanna Meriläinen, Elisa Mäkäräinen-Uhlbäck, Raila Aro, Tero Rautio, Juha Saarnio, Noora Ämmälä |
---|---|
Rok vydání: | 2019 |
Předmět: |
Lung Diseases
Male Sarcopenia Colorectal cancer Myocardial Infarction Anastomotic Leak Kaplan-Meier Estimate 0302 clinical medicine Postoperative Complications Registries Aged 80 and over General Medicine Middle Aged Prognosis Patient Discharge Survival Rate medicine.anatomical_structure Oncology Adipose Tissue 030220 oncology & carcinogenesis Body Composition 030211 gastroenterology & hepatology Female Colorectal Neoplasms Respiratory Insufficiency Adult medicine.medical_specialty Heart Diseases Rectum 03 medical and health sciences Young Adult Internal medicine medicine Humans Risk factor Muscle Skeletal Aged Proportional Hazards Models Retrospective Studies Heart Failure business.industry Carcinoma Cancer Cardiorespiratory fitness Pneumonia medicine.disease Pleural Effusion Surgery Complication business Pulmonary Embolism Tomography X-Ray Computed |
Zdroj: | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 46(9) |
ISSN: | 1532-2157 |
Popis: | The aim of this study was to evaluate whether sarcopenia or myosteatosis have an impact on short- and long-term results in patients who were surgically treated for colorectal cancer.During 2007-2011 curatively treated colorectal cancer patients (n = 348) were included in the study. Clinical data was collected retrospectively from patient registers. Skeletal muscle mass was measured at the L3 level via venous-phase computed tomography and patients were divided into sarcopenic and non-sarcopenic and into myosteatotic and non-myosteatotic. Postoperative morbidity and mortality were analysed in these groups.Sarcopenia was found in 208 patients (59.8%) and myosteatosis was found in 108 patients (31.2%). Sarcopenia was associated with increased risk of postoperative pneumonia (6.7% vs. 1.4%, p = 0.021). Sarcopenic colon cancer patients had higher rate of cardiorespiratory complications than non-sarcopenic (6.3% vs. 0.0%, p = 0.023) and sarcopenic rectum cancer patients had more often pneumonia than non-sarcopenic (8.5% vs. 0.0%, p = 0.041). Discharge to home was less common in myosteatotic patients than in non-myosteatotic patients (47.7% vs. 76.9%, p 0.001) and also in sarcopenic patients than in non-sarcopenic patients (62.7% vs. 75.5%, p = 0.013). Myosteatotic patients had decreased overall survival according to a Kaplan-Meier analysis (p = 0.002) and in the multivariable-adjusted Cox model (HR = 1.6, p = 0.034).Sarcopenia increases the pneumonia and cardiorespiratory complication rates. Sarcopenia and myosteatosis predicts the need for institutional care after colorectal cancer surgery. Sarcopenia and myosteatosis seem to be negative factors for colorectal cancer patients' survival. Myosteatosis is an independent risk factor for poor overall 5-year survival. |
Databáze: | OpenAIRE |
Externí odkaz: |